Japan Recommends Long-Acting G-CSF Filgrastim
This article was originally published in PharmAsia News
Executive Summary
Japan recommended for approval two pharmaceutical products on August 8, including the new long-acting G-CSF formulation G-Lasta (genetic recombinant pegfilgrastim) from Kyowa Hakko Kirin.